GEODE CAPITAL MANAGEMENT, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 57 filers reported holding TRINITY BIOTECH PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2021$40,000
-23.1%
13,9090.0%0.00%
Q1 2021$52,0000.0%13,9090.0%0.00%
Q4 2020$52,000
+92.6%
13,9090.0%0.00%
Q3 2020$27,000
-10.0%
13,9090.0%0.00%
Q2 2020$30,000
+100.0%
13,9090.0%0.00%
Q1 2020$15,000
-46.4%
13,909
-50.0%
0.00%
Q4 2019$28,000
+75.0%
27,818
+100.0%
0.00%
Q3 2019$16,000
-36.0%
13,9090.0%0.00%
Q2 2019$25,000
-35.9%
13,9090.0%0.00%
Q1 2019$39,000
-37.1%
13,909
-50.0%
0.00%
Q4 2018$62,000
+12.7%
27,818
+100.0%
0.00%
Q3 2018$55,000
-20.3%
13,9090.0%0.00%
Q2 2018$69,000
-51.4%
13,909
-42.1%
0.00%
Q1 2017$142,000
-43.0%
24,038
-33.6%
0.00%
Q4 2016$249,000
+72.9%
36,189
+230.6%
0.00%
Q3 2016$144,000
+17.1%
10,948
+0.6%
0.00%
Q2 2016$123,000
-2.4%
10,8840.0%0.00%
Q1 2016$126,000
-6.7%
10,884
-6.0%
0.00%
Q4 2015$135,00011,5790.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2017
NameSharesValueWeighting ↓
ACK Asset Management 928,000$10,616,0004.44%
GOLDMAN CAPITAL MANAGEMENT INC 350,961$4,015,0002.86%
Paradice Investment Management LLC 992,235$11,351,0002.07%
Centaur Capital 77,500$887,0001.33%
Adirondack Funds 302,305$3,458,0001.33%
Adirondack Research & Management Inc. 302,305$3,458,0001.33%
RK Capital 565,472$6,469,0001.18%
Lyon Street Capital, LLC 140,943$1,612,0001.17%
Benchmark Capital Advisors 89,941$1,029,0000.84%
KEANE CAPITAL MANAGEMENT INC 55,045$630,0000.83%
View complete list of TRINITY BIOTECH PLC shareholders